We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04235101
Title Phase I Study of SYD985 With Niraparib in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Byondis B.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | GBR | BEL

Facility Status City State Zip Country Details
University Hospital Antwerp, BE Antwerp 2650 Belgium Details
Institut Jules Bordet Brussel 1000 Belgium Details
Radboud University Medical Center/ NL Nijmegen 6500 HB Netherlands Details
The Royal Marsden NHS Foundation Trust London SM2 5PT United Kingdom Details
The Christie NHS Foundation Trust/ UK Manchester M20 4BX United Kingdom Details
The Newcastle upon Tyne Hospitals NHS Foundation Trust/UK Newcastle NE7 7DN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field